Hans Biomed Corp. | Cash Flow

Fiscal year is October-September. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,434
3,498
4,909
4,772
8,140
Depreciation, Depletion & Amortization
798
636
839
1,101
1,646
Other Funds
38
7,495
-
-
595
Funds from Operations
4,364
3,500
3,822
6,624
8,860
Changes in Working Capital
2,032
1,438
355
5,998
3,263
Net Operating Cash Flow
2,333
2,062
3,466
626
5,597
Capital Expenditures
8,402
13,154
6,072
9,713
13,465
Sale of Fixed Assets & Businesses
1
35
750
213
1,920
Purchase/Sale of Investments
4,209
1,460
95
-
190
Net Investing Cash Flow
4,451
11,645
5,168
9,505
11,106
Cash Dividends Paid - Total
-
-
-
942
942
Issuance/Reduction of Debt, Net
-
-
3,588
7,787
8,625
Net Financing Cash Flow
2,478
8,785
3,708
6,845
8,278
Net Change in Cash
359
800
1,966
1,992
2,787
Free Cash Flow
4,959
10,328
1,380
7,616
7,451
Other Sources
95
30
59
15
512
Change in Capital Stock
2,440
1,290
120
-
-
Exchange Rate Effect
-
1
40
42
17
Other Uses
354
15
-
20
263

About Hans Biomed

View Profile
Address
7 Jeongui-ro 8-gil
Seoul SL 05836
Korea, Republic Of
Employees -
Website http://www.hansbiomed.com
Updated 09/14/2018
HansBiomed Co., Ltd. engages in the manufacture and sale of graft material and silicon products. Its products include skin and bone graft material, silicon material, and other medical appliances. The company was founded on September 15,1999 and is headquartered in Seoul, South Korea.